Drugs / CLIC-1901
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03765177 | Oct 2019 → Jan 2027 expected | chronic lymphocytic leukemia/small lymphocytic lymphoma | Ottawa Hospital Research Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLIC-1901 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03765177 ↗ |
| Modality | Cell therapy | “CLIC-1901 cell therapy” NCT03765177 ↗ |
| Route | Intravenous | “All treatments will be delivered intravenously.” NCT03765177 ↗ |